Häftad, Engelska, 2025
Nanocarriers in Prostate Cancer
Advanced Diagnosis and Treatment Strategies
Av Bhupendra G. Prajapati, Devesh U. Kapoor, Nemat Ali, Anand Krishnan
1766 kr
Beställningsvara. Skickas inom 11-20 vardagar. Fri frakt över 249 kr.
Beskrivning
This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies.
- Provides in-depth coverage of nanocarrier types, showcasing their specific roles in prostate cancer treatment
- Integrates the latest research findings with practical clinical applications
- Offers valuable insights and practical examples that help advance understanding and application of nanotechnology in prostate cancer therapy
Produktinformation
- Utgivningsdatum: 2025-11-28
- Mått: 191 x 235 x undefined mm
- Vikt: 780 g
- Format: Häftad
- Språk: Engelska
- Antal sidor: 376
- Förlag: Elsevier Science
- ISBN: 9780443332081
Utforska kategorier
Mer om författaren
Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.Dr. Anand Krishnan, Principal Investigator, Department of Haematology and Cell Biology, School of Pathology, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) Research Lab, which focuses on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research focuses on establishing an extracellular vesicle (EV) biofoundry by integrating synthetic biology. His research encompasses cell modification, therapeutic target, biomarker discovery from EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development. Dr. Krishnan has authored over 150 articles and edited ten books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organization for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.
Recensioner i media
Select Guide Rating
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.